Butyrylcholinesterase: a target in the cholinergic treatment of Alzheimer's disease

By Potkin Steven G.  

Primary Care Psychiatry, Vol. 9, Iss. 3, 2004-09 ,pp. : 83-87

Informa Healthcare

Access to resources Recommend Favorite

Cell Degeneration Induced by Amyloid-β Peptides: Implications for Alzheimer's Disease

By Pereira Cláudia   Ferreiro Elisabete   Cardoso Sandra Morais   de Oliveira Catarina Resende  

Journal of Molecular Neuroscience, Vol. 23, Iss. 1-2, 2004-04 ,pp. : 97-104

Humana Press, Inc

Access to resources Recommend Favorite

Amyloid-&bgr; Peptides, Alzheimer's Disease and the Blood-brain Barrier

By  

Current Alzheimer Research, Vol. 10, Iss. 10, 2013-12 ,pp. : 1015-1033

Bentham Science Publishers

Access to resources Recommend Favorite

Discovery of a new class of synthetic protein kinase inhibitors that suppress selective aspects of glial activation and protect against β-amyloid induced injury: A foundation for future medicinal chemistry efforts focused on targeting Alzheimer’s disease progression

By Watterson D.   Velentza Anastasia   Zasadzki Magdalena   Craft Jeffrey   Haiech Jacques   Eldik Linda  

Journal of Molecular Neuroscience, Vol. 20, Iss. 3, 2003-08 ,pp. : 411-423

Humana Press, Inc

Access to resources Recommend Favorite

The Anti-Inflammatory Role of Minocycline in Alzheimer´s Disease

By  

Current Alzheimer Research, Vol. 13, Iss. 12, 2016-12 ,pp. : 1319-1329

Bentham Science Publishers

Access to resources Recommend Favorite